跳至主要内容
临床试验/CTRI/2019/11/021858
CTRI/2019/11/021858进行中(未招募)3 期

AN OPEN LABEL CLINICAL INTERVENTIONAL TRIAL TO FIND OUT THE EFFICACY OF HOMOEOPATHIC MEDICINES IN REDUCING ANTIBODY LEVELS IN AUTOIMMUNE THYROIDITIS

VISHNUPRIYA S V0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with either ATPO above 35 IU/ml or Anti Tg above 20IU/ml or Thyroid-stimulating hormone (TSH) receptor binding inhibitor immunoglobulin (TBII)/ TRAb more than 1.75 IU/

排除标准

  • Hypothyroidism associated with thyroid malignancies
  • Patients with other severe systemic illness like uncontrolled diabetes, malignant hypertension, other malignancies etc.
  • Immuno compromised patients
  • Pregnant ladies and lactating mothers

研究者

发起方
VISHNUPRIYA S V

相似试验